APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING TO PREDICT ONDANSETRON PHARMACOKINETICS IN CHILDREN

被引:0
|
作者
Zhou, W. [1 ]
Johnson, T. [2 ]
Bui, K. [1 ]
Cheung, A. [3 ]
Li, J. [1 ]
Xu, H. [1 ]
Al-Huniti, N. [1 ]
Zhou, D. [1 ]
机构
[1] AstraZeneca, Waltham, MA USA
[2] Certara, Sheffield, S Yorkshire, England
[3] AstraZeneca, Cambridge, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PII-155
引用
收藏
页码:S94 / S95
页数:2
相关论文
共 50 条
  • [1] Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict Desloratadine Pharmacokinetics in Children
    Zhou, W.
    Johnson, T.
    Bui, K.
    Cheung, S. Y. A.
    Li, J.
    Xu, H.
    Al-Huniti, N.
    Zhou, D.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S138 - S138
  • [2] Application of Physiologically Based Pharmacokinetic Modeling to Predict Raltegravir Pharmacokinetics in Children
    Zhou, Wangda
    Johnson, Trevor
    Bui, Khanh
    Cheung, S. Y. Amy
    Li, Jianguo
    Xu, Hongmei
    Al-Huniti, Nidal
    Zhou, Diansong
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S43 - S43
  • [3] Application of Physiologically Based Pharmacokinetic Modeling to Predict Acetaminophen Metabolism and Pharmacokinetics in Children
    Jiang, X-L
    Zhao, P.
    Barrett, J. S.
    Lesko, L. J.
    Schmidt, S.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (10):
  • [4] Physiologically Based Pharmacokinetic (PBPK) Modeling in Children
    Barrett, J. S.
    Alberighi, O. Della Casa
    Laeer, S.
    Meibohm, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) : 40 - 49
  • [5] Application of Physiologically Based Pharmacokinetic Modeling to Predict Pharmacokinetics in Healthy Japanese Subjects
    Matsumoto, Yuki
    Cabalu, Tamara
    Sandhu, Punam
    Hartmann, Georgy
    Iwasa, Takashi
    Yoshitsugu, Hiroyuki
    Gibson, Christopher
    Uemura, Naoto
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (04) : 1018 - 1030
  • [6] PREDICTIVE PERFORMANCE OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF SUFENTANIL IN CHILDREN
    Zhou, W.
    Johnson, T.
    Bui, K.
    Cheung, A.
    Li, J.
    Xu, H.
    Al-Huniti, N.
    Zhou, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S94 - S94
  • [7] Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine
    He, Lixia
    Ke, Meng
    Wu, Wanhong
    Chen, Jiarui
    Guo, Guimu
    Lin, Rongfang
    Huang, Pinfang
    Lin, Cuihong
    PHARMACEUTICS, 2022, 14 (11)
  • [8] Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment
    Wu, Wanhong
    Ke, Meng
    Ye, Lingling
    Lin, Cuihong
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (07) : 989 - 998
  • [9] Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment
    Wanhong Wu
    Meng Ke
    Lingling Ye
    Cuihong Lin
    European Journal of Clinical Pharmacology, 2021, 77 : 989 - 998
  • [10] Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Irbesartan in Different CYP2C9 Genotypes
    Lee, Seok-Yong
    Cho, Chang-Keun
    Kang, Pureum
    Ko, Eunvin
    Mu, Chou Yen
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385